MedTrace Logo

Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

NCT03225248 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2017-07-21

No results posted yet for this study

Summary

This study is a multi-center, randomized, active-controlled, double-blind, non-inferiority, phase III clinical trial evaluating efficacy and safety of once-daily mosapride (UI05MSP015CT) in patients with functional dyspepsia.

Conditions

  • Functional Dyspepsia

Interventions

DRUG

UI05MSP015CT

UI05MSP015CT and Placebo of Gasmotin

DRUG

Gasmotin

Placebo of UI05MSP015CT and Gasmotin

Sponsors & Collaborators

  • Korea United Pharm. Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-05
Primary Completion
2015-09-05
Completion
2015-10-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225248 on ClinicalTrials.gov